The effect of verapamil on the restoration of myocardial perfusion and functional recovery in patients with angiographic no-reflow after primary percutaneous coronary intervention

Nuclear Medicine Communications

Volumn 27, Issue 3, 2006, Pages 247-254

  Umemura, Shigeo ^a   Nakamura, Seishi ^b   Sugiura, Tetsuro ^c   Tsuka, Yoshiaki ^c   Fujitaka, Keisuke ^c   Yoshida, Susumu ^c   Baden, Masato ^c   Iwasaka, Toshiji ^c  

^a Takarazuka Hospital   (Belgium)

^b KOCHI MEDICAL SCHOOL   (Japan)

^c KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Acute myocardial infarction; Angiographic no reflow phenomenon; Percutaneous transluminal coronary intervention; Technetium 99m tetrofosmin; Verapamil

Indexed keywords

VERAPAMIL; ACETYLSALICYLIC ACID; TETROFOSMIN TC 99M;

AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; DRUG EFFECT; HEART INFARCTION; HUMAN; MALE; REPERFUSION INJURY; SCINTISCANNING; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; ADULT; ANGIOCARDIOGRAPHY; DEMOGRAPHY; DOSE RESPONSE; DRUG FORMULATION; ECHOCARDIOGRAPHY; FEMALE; HEART MUSCLE PERFUSION; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; MULTIPLE REGRESSION; PERCUTANEOUS CORONARY INTERVENTION; SCORING SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; HUMANS; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; RECOVERY OF FUNCTION; TREATMENT OUTCOME; VERAPAMIL;

EID: 33646695910     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200603000-00007     Document Type: Article

References (30)

1. Piana RN, Paik GY, Moscucci M, Cohen DJ, Gibson CM, Kugelmass AD, et al. Incidence and treatment of ‘no-reflow’ after percutaneous coronary intervention. Circulation 1994; 89:2514-2518.
2. Morishima I, Sone T, Okumura K, Tsuboi H, Kondo J, Mukawa H, et al. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol 2000; 36:1202-1209.
3. Morishima I, Sone T, Mokuno S, Taga S, Shimauchi A, Oki Y, et al. Clinical significance of no-reflow phenomenon observed on angiography after successful treatment of acute myocardial infarction with percutaneous transluminal coronary angioplasty. Am Heart J 1995; 130:239-243.
4. Taniyama Y, Ito H, Iwakura K, Masuya T, Masatsugu H, Takiuchi S, et al. Beneficial effect of intracoronary verapamil on microvascular and myocardial salvage in patients with acute myocardial infarction. J Am Coll Cardiol 1997; 30:1193-1199.
5. Nakamura S, Takehana K, Sugiura T, Hatada K, Hamada S, Asada J, et al. Quantitative estimation of myocardial salvage after primary percutaneous transluminal coronary angioplasty in patients with angiographic no reflow. Eur J Nucl Med Mol Imaging 2003; 30:383-389.
6. Wackers FJT, Gibbons RJ, Verani MS, Kayden DS, Pellikka PA, Behrenbeck T, et al. Serial quantitative planar technetium-99m isonitrile imaging in acute myocardial infarction: efficacy for noninvasive assessment of thrombolytic therapy. J Am Coll Cardiol 1989; 14:861-873.
7. Christian TF, Schwartz RS, Gibbons RJ. Determinants of infarct size in reperfusion therapy for acute myocardial infarction. Circulation 1992; 86:81-90.
8. Clements IP, Christian TF, Higano ST, Gibbons RJ, Gersh BJ. Residual flow to the infarct zone as a determinant of infarct size after direct angioplasty. Circulation 1993; 88(pt I):1527-1533.
9. Laster SB, O'Keefe JH, Gibbons RJ. Incidence and importance of thrombolysis in myocardial infarction grade 3 flow after primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. Am J Cardiol 1996; 78:623-626.
10. Karagounis L, Sorensen SG, Menlove RL, Moreno F, Anderson JL. Does thrombolysis in myocardial infarction (TIMI) perfusion represent a mostly patent artery or a mostly occluded artery? Enzymatic and electrocardiographic evidence from the TEAM-2 study. J Am Coll Cardiol 1992; 19:110.
11. Hamada S, Nakamura S, Sugiura T, Murakami T, Fujimoto T, Watanabe J, et al. Early detection of the no-reflow phenomenon in reperfused acute myocardial infarction using technetium-99m tetrofosmin imaging. Eur J Nucl Med 1999; 26:208-214.
12. Hamada S, Nakamura S, Sugiura T, Nishiue T, Watanabe J, Hatada K, et al. Accuracy of technetium-99m tetrofosmin myocardial perfusion imaging in the detection of spontaneous recanalization in patients with acute anterior myocardial infarction. Eur J Nucl Med 2001; 28:327-333.
13. Watanabe J, Nakamura S, Sugiura T, Takehana K, Hamada S, Miyoshi H, et al. Early identification of impaired myocardial reperfusion with serial assessment of ST segments after percutaneous transluminal coronary angioplasty during acute myocardial infarction. Am J Cardiol 2001; 88:956-959.
14. Rentrop KP, Cohen M, Blanke H, Phillips RA. Change in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 1985; 5:587-592.
15. Ito H, Okamura A, Iwakura K, Masuyama T, Hori M, Takiuchi S, et al. Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction. Circulation 1996; 93:1993-1999.
16. Ito H, Tomooka T, Sakai N, Higashino Y, Fujii K, Katoh O, et al. Time course of functional improvement in stunned myocardial in risk area in patients with reperfused anterior infarction. Circulation 1993; 87:355-362.
17. Sinusas AJ, Trautman KA, Bergin JD, Watson DD, Ruiz M, Smith WH, et al. Quantification of area at risk during coronary occlusion and degree of myocardial salvage after reperfusion with technetium-99m methoxyisobutyl isonitrile. Circulation 1990; 82:1424-1437.
18. Kenner MD, Zajac EJ, Kondos GT, Dave R, Winklelmann JW, Joftus J, et al. Ability of the no-reflow phenomenon during an acute myocardial infarction to predict left ventricular dysfunction at one-month follow-up. Am J Cardiol 1995; 76:861-868.
19. Yamamoto K, Ito H, Iwakura K, Kawano S, Kiushima M, Masuyama T, et al. Two different coronary blood flow velocity patterns in thrombolysis in myocardial infarction flow grade 2 in acute myocardial infarction: insight into mechanisms of microvascular dysfunction. J Am Coll Cardiol 2002; 40:1755-1760.
20. Van't Hof AW, Liem A, Suryapranata H, Hoorntje JC, de Boer MJ, Zijlstra F. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group. Circulation 1998; 97:2302-2306.
21. Gibson CM, Cannon CP, Daley WL, Dodge Jr JT, Alexander B, Marble SJ, et al. TIMI frame count. A quantitative method for assessing coronary artery flow. Circulation 1996; 93:879-888.
22. Hamada S, Nishiue T, Nakamura S, Sugiura T, Kamihata H, Miyoshi H, et al. TIMI frame count immediately after primary coronary angioplasty as a predictor of functional recovery in patients with TIMI 3 reperfused acute myocardial infarction. J Am Coll Cardiol 2001; 38:666-671.
23. Ragosta M, Camarano G, Kaul S, Powers ER, Sarembock IJ, Gimple LW. Microvascular integrity indicates myocellular viability in patients with recent myocardial infarction. New insights using myocardial contrast echocardiography. Circulation 1994; 89:2562-2569.
24. 99mTc-tetrofosmin assessment of myocardial perfusion and viability in canine models of coronary occlusion and reperfusion. J Nucl Med 1999; 40:142-149.
25. Miller TD, Christian TF, Hopfenspirger MR, Hodge DO, Gersh BJ, Gibbons RJ. Infarct size after acute myocardial infarction measured by quantitative tomographic technetium-99m sestamibi imaging predicts subsequent mortality. Circulation 1995; 92:334-341.
26. Matsunari I, Tanishima Y, Taki J, Ono K, Nishide H, Fujino S, et al. Early and delayed technetium-99m-tetrofosmin myocardial SPECT compared in normal volunteers. J Nucl Med 1996; 37:1622-1626.
27. Jain D, Wackers FJT, Mattera J, McMahon M, Sinusas AJ, Zalet BL. Biokinetics of technetium-99m-tetrofosmin: myocardial perfusion imaging agent: Implications for a one-day imaging protocol. J Nucl Med 1993; 34:1254-1259.
28. Sridhara BS, Braat S, Rigo P, Itti R, Cload P, Lahiri A. Comparison of myocardial perfusion imaging with technetium-99m-tetrofosmin versus thallium-201 in coronary artery disease. Am J Cardiol 1993; 72:1015-1019.
29. de Boer MJ, Suryapranata H, Hoorntje JCA, Reiffers S, Liem AL, Miedema K, et al. Limitation of infarct size and preservation of left ventricular function after primary coronary angioplasty compared with intravenous streptokinase in acute myocardial infarction. Circulation 1994; 90:753-761.
30. Grines CL, Browne KF, Marco J, Rothbaum D, Stone GW, O'Keefe J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993; 328:673-679.